Health Care Fund Expands Drug Reimbursement List in April The Health Care Fund announced an expansion of its list of eligible drugs for reimbursement in April, aiming to improve access to necessary health care. The expansion includes coverage for a range of medications addressing conditions such as short-sightedness, atopic keratoconjunctivitis (ATH), psoriatic arthritis, and nail fungus. This broadened coverage provides support for individuals managing chronic and specific health needs. The initiative reflects a continued commitment to enhancing patient care and reducing financial burdens associated with treatment. Approximately 1.528 million euros is anticipated to be invested in the reimbursement of these new drugs within the initial year. The additions represent a significant step in the Health Care Fund’s efforts to provide comprehensive drug coverage for patients with various conditions, including those related to cancer, eye health, autoimmune diseases, and mental health concerns. The changes underscore the ongoing focus on accessible and affordable health care options for the public. Further details regarding the specific drugs and reimbursement criteria are available on the Health Care Fund’s website. Topics: #drugs #health #care Post navigation Jüri Toomepuu ⟩ Orbán’s career may not be over yet, but something in him has irreversibly changed Kalle Laanet: We can win on two fronts at the same time